Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%

Trials by Status

completed250%
recruiting125%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast Tissue

NCT06127797
unknown

Impact of Hybrid Closed Loop Systems in People With Type I Diabetes

NCT05348499
completed

Evaluating Barriers to Stroke Screening and Prevention in Children With Sickle Cell Disease

NCT03621826
completed

Evaluation of Nocturnal Enuresis and Barriers to Treatment Among Pediatric Patients With Sickle Cell Disease

NCT01959958

Clinical Trials (4)

Showing 4 of 4 trials
NCT06127797

Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast Tissue

Recruiting
NCT05348499

Impact of Hybrid Closed Loop Systems in People With Type I Diabetes

Unknown
NCT03621826

Evaluating Barriers to Stroke Screening and Prevention in Children With Sickle Cell Disease

Completed
NCT01959958

Evaluation of Nocturnal Enuresis and Barriers to Treatment Among Pediatric Patients With Sickle Cell Disease

Completed

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4